Search Results - "Esselmann, H"

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study by Lewczuk, P, Kamrowski-Kruck, H, Peters, O, Heuser, I, Jessen, F, Popp, J, Bürger, K, Hampel, H, Frölich, L, Wolf, S, Prinz, B, Jahn, H, Luckhaus, Ch, Perneczky, R, Hüll, M, Schröder, J, Kessler, H, Pantel, J, Gertz, H-J, Klafki, H-W, Kölsch, H, Reulbach, U, Esselmann, H, Maler, J M, Bibl, M, Kornhuber, J, Wiltfang, J

“…In this report, we present the results of a multicenter study to test analytic and diagnostic performance of soluble forms of amyloid precursor proteins α and…”
Get full text

Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer’s disease and other neurodegenerative dementias by Genius, J., Klafki, H., Benninghoff, J., Esselmann, H., Wiltfang, J.

“…In light of the dramatically increasing prevalence of Alzheimer’s disease (AD) to be expected in the future, the development of novel therapeutics, improved…”
Get full text

Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias by BIBL, M, MOLLENHAUER, B, WILTFANG, J, LEWCZUK, P, ESSELMANN, H, WOLF, S, TRENKWALDER, C, OTTO, M, STIENS, G, RÜTHER, E, KORNHUBER, J

“…Biomarkers for differential diagnosis of the three most frequent degenerative forms of dementia, Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and…”
Get full text

From Bones to Brain: 50 Years of Star Trek and Changes in the Stigmatization of Psychological Disorders by Basilowski, M., Schönfeld, B., Esser, S., Jatho, A., Kownatka, M., Signerski-Krieger, J., Esselmann, H., Grabemann, M., Mette, C., Strunz, L., Zimmermann, M., Lajcsak, E., Scherbaum, N., Wiltfang, J., Kis, B., Abdel-Hamid, M.

“…The Star Trek franchise currently includes five spin-off series and 13 motion pictures. Star Trek’s central theme is the utopian future of mankind, but the…”
Get full text

Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammation by Wiltfang, J., Esselmann, H., Bibl, M., Smirnov, A., Otto, M., Paul, S., Schmidt, B., Klafki, H.‐W., Maler, M., Dyrks, T., Bienert, M., Beyermann, M., Rüther, E., Kornhuber, J.

“…Human lumbar CSF patterns of Aβ peptides were analysed by urea‐based β‐amyloid sodium dodecyl sulphate polyacrylamide gel electrophoresis with western…”
Get full text

Guideline-adherent inpatient psychiatric psychotherapeutic treatment of behavioral and psychological symptoms of dementia : Normative definition of personnel requirements by Radenbach, K, Retzlik, J, Meyer-Rötz, S H, Wolff-Menzler, C, Wolff, J, Esselmann, H, Godemann, F, Riemenschneider, M, Wiltfang, J, Jessen, F

“…Dementia is of increasing medical and societal relevance. Hospitalization of dementia patients is mostly due to behavioral and psychological symptoms of…”
Get full text

Plasma lipoprotein beta-amyloid in subjects with Alzheimer's disease or mild cognitive impairment by Mamo, J C L, Jian, L, James, A P, Flicker, L, Esselmann, H, Wiltfang, J

“…Plasma amyloid beta-peptide (Abeta) can compromise the blood-brain barrier, contributing to cerebrovascular alterations and amyloid angiopathy in Alzheimer's…”
Get more information

Decreased β-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease by OTTO, M, ESSELMANN, H, KORNHUBER, J, KRETZSCHMAR, H. A, POSER, S, WILTFANG, J, SCHULZ-SCHAEFFER, W, NEUMANN, M, SCHRÖTER, A, RATZKA, P, CEPEK, L, ZERR, I, STEINACKER, P, WINDL, O

“…Decreased levels of Abeta1-42 are found in CSF of patients with AD. Because early stages of Creutzfeldt-Jakob disease (CJD) and AD share several clinical…”
Get full text

Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations by Bibl, M., Mollenhauer, B., Wolf, S., Esselmann, H., Lewczuk, P., Kornhuber, J., Wiltfang, J.

“…Cerebrospinal fluid (CSF) carboxyterminally truncated amyloid-beta (A beta ) peptides, A beta 1-42 and tau protein were evaluated in 30 patients with…”
Get full text

Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis? by Mollenhauer, B, Bibl, M, Esselmann, H, Steinacker, P, Trenkwalder, C, Wiltfang, J, Otto, M

“…To evaluate variations in amyloid beta (Abeta) peptide pattern in cerebrospinal fluid (CSF) in neurodegenerative disorders. A recently established quantitative…”
Get full text

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies by Bibl, M, Mollenhauer, B, Esselmann, H, Lewczuk, P, Trenkwalder, C, Brechlin, P, Rüther, E, Kornhuber, J, Otto, M, Wiltfang, J

“…Differential diagnosis of Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) is often crucial. CSF Tau protein and Amyloid-beta (A beta) peptides…”
Get full text

Consensus Paper of the WFSBP Task Force on Biological Markers of Dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia by Wiltfang, J., Lewczuk, P., Riederer, P., Grünblatt, E., Hock, C., Scheltens, P., Hampel, H., Vanderstichele, H., Iqbal, K., Galasko, D., Lannfelt, L., Otto, M., Esselmann, H., Henkel, A. W., Kornhuber, J., Blennow, K.

“…Aging of population, and increasing life expectancy result in an increasing number of patients with dementia. This symptom can be a part of a completely…”
Get full text

Aminoterminally truncated and oxidized amyloid-beta peptide species in Alzheimer’s disease by Bibl, M, Esselmann, H, Mollenhauer, B, Wiltfang, J

Get full text

Immune complexes of auto-antibodies against Aβ1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients by HENKEL, A. W, DITTRICH, P. S, WILTFANG, J, GROEMER, T. W, LEMKE, E. A, KLINGAUF, J, KLAFKI, H. W, LEWCZUK, P, ESSELMANN, H, SCHWILLE, P, KORNHUBER, J

“…The diagnostic potential of large Aβ-peptide binding particles (LAPs) in the cerebrospinal fluid (CSF) of Alzheimer's dementia (AD) patients and non-AD…”
Get full text

Immune complexes of auto-antibodies against A beta 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients by Henkel, A W, Dittrich, P S, Groemer, T W, Lemke, E A, Klingauf, J, Klafki, H W, Lewczuk, P, Esselmann, H, Schwille, P, Kornhuber, J, Wiltfang, J

“…The diagnostic potential of large A beta-peptide binding particles (LAPs) in the cerebrospinal fluid (CSF) of Alzheimer's dementia (AD) patients and non-AD…”
Get full text

P01-496 - Comparative study of the effects of intranasal insulin on memory deficits in type 2 diabetes and early Alzheimer's dementia concept and study scope by Siemann, H, Müller, B, Stein, E.M, Esselmann, H, Loos, S, Ennen, J, Lehnert, H, Hallschmid, M, Wiltfang, J

“…Introduction Recent data support the view that the neurodegeneration underlying sporadic Alzheimer's Disease (AD) is in part related to brain insulin…”
Get full text

Tyr687 dependent APP endocytosis and Abeta production by Rebelo, Sandra, Vieira, Sandra Isabel, Esselmann, Hermann, Wiltfang, Jens, da Cruz e Silva, Edgar F, da Cruz e Silva, Odete A B

“…The neurotoxic Abeta peptide is derived by proteolytic processing from the Alzheimer's amyloid precursor protein (APP), whose short cytoplasmic domain contains…”
Get full text

3-D Coculture of Hepatic Sinusoidal Cells with Primary Hepatocytes—Design of an Organotypical Model by Bader, A., Knop, E., Kern, A., Böker, K., Frühauf, N., Crome, O., Esselmann, H., Pape, C., Kempka, G., Sewing, K.-Fr

“…Models for cocultures of parenchymal (PC) and nonparenchymal cells (NPC) of the liver relied on mixing the cells in a two-dimensional configuration or on…”
Get full text

Selective reduction of amyloid beta 42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation by Mollenhauer, B, Bibl, M, Esselmann, H, Steinacker, P, Trenkwalder, C, Brechlin, P, Wiltfang, J, Otto, M

Get full text

Selective reduction of amyloid β42 discriminates Alzheimer’s disease from Huntington’s disease: indication for distinct pathological events in amyloid β peptide aggregation by Mollenhauer, B, Bibl, M, Esselmann, H, Steinacker, P, Trenkwalder, C, Brechlin, P, Wiltfang, J, Otto, M

Get full text